New study testing a pill that may help muscle health and metabolism begins
A Swedish biotech company called Atrogi has started giving people a new experimental pill called ATR-258 to see if it […]
Pharmaceutical News
Novartis to Acquire Biotech Company for $3 Billion to Develop New Breast Cancer Treatments
Novartis, a leading global pharmaceutical company, is purchasing Pikavation Therapeutics, a small biotech company owned by Synnovation Therapeutics, for up
Pharmaceutical Companies Team Up to Develop New Medicines for Serious Conditions
Samsung Bioepis, a company that makes copies of biologic medicines (called biosimilars), has signed a new global deal with Sandoz,
New Hope for Cancer Treatment: DT-9081 Shows Promise in Early Trials
Kainova Therapeutics has shared positive early results from their first-stage study of DT-9081, a new oral medicine being developed for
Pharmaceutical News
Lundbeck Welcomes New AI Leader to Boost Brain Health Research
Lundbeck, a company focused on brain health, has hired Markus Kede as its new Senior Vice President and Chief AI
Parkinson’s Research at a Turning Point, but Challenges Remain
Parkinson’s disease research is at a crucial stage, but there are still hurdles to overcome, says an expert in the
Big Moment in Parkinson’s Research, But Challenges Remain
Hello, I’m your friendly pharmacist. I’ve been keeping an eye on some exciting news about Parkinson’s disease research. Scientists have
Making the Path to Medicine Easier: A Pharmacist’s Guide to Process Performance Qualification
A crucial but often overlooked step in bringing new medicines to patients is something called Process Performance Qualification (PPQ). This
GSK’s RSV Vaccine Approved for More Adults, Easing Healthcare Pressure
On Friday, the Food and Drug Administration (FDA) gave GSK’s respiratory syncytial virus (RSV) vaccine, Arexvy, an expanded approval. This
Pharmaceutical News
New Hope for Rare Epilepsy Treatment: Zorevunersen Shows Promise
A new drug called zorevunersen, developed by Biogen and Stoke Therapeutics, has shown potential to be the first treatment that